Symmetry of PML is a dubious disease in the field of the nervous system, with clinical performance being complex and often involving multi-system congestion. Early identification and standardised clinical care are essential for improving prognosis. Diagnosis of PML requires a combination of clinical performance, imaging, laboratory testing and pathological activation.
A platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment. Treatment and management of PML symmetry require individual treatment regimens, usually including drug therapy, rehabilitation interventions, and regular follow-up to multiple-dimensional management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many neurological diseases that have been difficult to treat have been significantly improved.
Treatment requires close monitoring of therapeutic effects and adverse reactions and timely adjustment according to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of PML. The platform serves a team of domestic and foreign experts in the field of neural systems aligned with the China International Medical Service System, providing the following services to patients: 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.